Lineage Cell Therapeutics
LCTX
#8657
Rank
$0.11 B
Marketcap
$0.60
Share price
-6.45%
Change (1 day)
-43.93%
Change (1 year)

Lineage Cell Therapeutics (LCTX) - Total debt

Total debt on the balance sheet as of June 2024 : $2.95 Million USD

According to Lineage Cell Therapeutics 's latest financial reports the company's total debt is $2.95 Million USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Lineage Cell Therapeutics - Total debt on balance sheet (from 2001 to 2024)

Total debt by year

Year Total debt Change
2023-12-31$2.95 M-24.23%
2022-12-31$3.89 M39.04%
2021-12-31$2.8 M-26.75%
2020-12-31$3.82 M-25.99%
2019-12-31$5.16 M128.17%
2018-12-31$2.26 M47.75%
2017-12-31$1.53 M-61.5%
2016-12-31$3.98 M-21.97%
2015-12-31$5.1 M868.31%
2014-12-31$0.52 M
2013-12-31N/A
2008-12-31$1.88 M163.17%
2007-12-31$0.71 M
2003-12-31$2.68 M23.82%
2002-12-31$2.16 M25.28%
2001-12-31$1.73 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
$2.77 M-6.13%๐Ÿ‡บ๐Ÿ‡ธ USA